Deepak Patel And Indivjal Dhasmana

Stories by Deepak Patel And Indivjal Dhasmana

Roll back ban on Rs 500 note, says ex-chief economic advisor Basu

Roll back ban on Rs 500 note, says ex-chief economic advisor Basu

Rediff.com   29 Nov 2016

'Demonetisation may have been well-intentioned, but it was a major mistake. The government should reverse it. It could at least declare that Rs 500 notes, which many poorer people frequently use, are legal again,' Basu, who till recently was World Bank vice-president, wrote in an opinion piece in The New York Times.

Rs 1.28 lakh cr! That's the cost of demonetisation according to CMIE

Rs 1.28 lakh cr! That's the cost of demonetisation according to CMIE

Rediff.com   25 Nov 2016

The study says the entire supply chain of goods and services will suffer a massive liquidity shock.

'By mid-January, transaction problems will be over'

'By mid-January, transaction problems will be over'

Rediff.com   21 Nov 2016

'Because of the government's step, the people are now going to splurge on consumption.' 'If you ask me, would growth be 8% for 2017-2018, I would say 7.5% because of the demonetisation move would not be very significant.'

Beware, taxmen to watch your posts on social media

Beware, taxmen to watch your posts on social media

Rediff.com   18 Nov 2016

Information gathered from a person's social media account will be matched with his or her declared income.

Demonetisation to hit short term economic growth

Demonetisation to hit short term economic growth

Rediff.com   10 Nov 2016

Significant portion of the funds used to fuel urban demand have become illegal and inoperative.

With inflation slowing, there is space for monetary easing: Arvind Subramanian

With inflation slowing, there is space for monetary easing: Arvind Subramanian

Rediff.com   29 Sep 2016

Chief Economic Advisor Arvind Subramanian says that he hopes GDP growth will be at the upper end of the 7-7.5 per cent range.

Five-Year Plans officially declared dead from FY17

Five-Year Plans officially declared dead from FY17

Rediff.com   24 Sep 2016

The Niti Aayog is preparing 15-year vision document that will replace the Five-Year Plan from the next financial year

They will help Urjit Patel to take a call on interest rates

They will help Urjit Patel to take a call on interest rates

Rediff.com   23 Sep 2016

Chetan Ghate, Pami Dua and Ravindra Dholakia have been appointed for 4 years

GST timeline: Twists and turns along the way

GST timeline: Twists and turns along the way

Rediff.com   4 Aug 2016

The Rajya Sabha on Wednesday approved the biggest tax reform since Independence.

GST: Miles to go for a smooth journey

GST: Miles to go for a smooth journey

Rediff.com   4 Aug 2016

For the government to meet its GST roll-out deadline of April 1, 2017, the states will have to ratify the Bill before Parliament's winter session, starting November.

Why India Inc is upbeat on economy, higher profits

Why India Inc is upbeat on economy, higher profits

Rediff.com   18 Jul 2016

Lack of political consensus on economic reforms a key concern.

'FDI policy should be seen in light of Make in India'

'FDI policy should be seen in light of Make in India'

Rediff.com   15 Jul 2016

With EU, it is part of the FTA that we will need to negotiate.

Govt open to Cong's idea of ring-fencing GST rate

Govt open to Cong's idea of ring-fencing GST rate

Rediff.com   10 Jul 2016

Cong leaders speak in two voices but final stand may be decided at a meeting headed by Rahul Gandhi next week

A game-changer who is stuck at the MoS level

A game-changer who is stuck at the MoS level

Rediff.com   8 Jul 2016

There was buzz of Piyush Goyal being elevated to Cabinet rank but only Prakash Javadekar made the cut.

Pay revision: Which states will suffer the most

Pay revision: Which states will suffer the most

Rediff.com   5 Jul 2016

Gujarat and Jharkhand are most favourably placed in terms of smaller share of public sector employees and lower liability on pension, wages and salaries.

Regulator finds Alkem Labs drug substandard, again

Regulator finds Alkem Labs drug substandard, again

Rediff.com   9 Jun 2016

The regulator had issued alerts in June and July of 2015.

Toxins in cough syrups, other drugs due to plastic bottling

Toxins in cough syrups, other drugs due to plastic bottling

Rediff.com   1 Jun 2016

Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.

Don't need to sell assets, can pay fine: Ranbaxy brothers

Don't need to sell assets, can pay fine: Ranbaxy brothers

Rediff.com   25 May 2016

In 2013, Daiichi had launched the arbitration proceedings in Singapore.

'No anti-worker steps will be taken by the government'

'No anti-worker steps will be taken by the government'

Rediff.com   24 May 2016

'Now, we have a minimum pension of Rs 1,000 annually.'

6 major companies found manufacturing 'substandard' drugs

6 major companies found manufacturing 'substandard' drugs

Rediff.com   18 May 2016

Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.